« Back
Home /
VLX1570

VLX1570

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Amount	1 mg
Item no.	HY-12471-1mg
Targets	Deubiquitinase
CASRN	1431280-51-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	VLX1570 is a competitive inhibitor of proteasome deubiquitinases (DUBs) with an IC50 of approximate 10 μM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	469.39
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer
Solubility	DMSO : ≥ 32 mg/mL
Manufacturers Target	Deubiquitinase
Pathway	Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12471-1mg-safety-datasheet.pdf